Polynovo Ltd
ASX:PNV
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.34
2.72
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one PNV stock under the Base Case scenario is 0.81 AUD. Compared to the current market price of 1.98 AUD, Polynovo Ltd is Overvalued by 59%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Polynovo Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for PNV cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Polynovo Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Polynovo Ltd
Balance Sheet Decomposition
Polynovo Ltd
Current Assets | 79.3m |
Cash & Short-Term Investments | 46m |
Receivables | 20.7m |
Other Current Assets | 12.6m |
Non-Current Assets | 29.4m |
PP&E | 24.2m |
Intangibles | 909k |
Other Non-Current Assets | 4.4m |
Current Liabilities | 23.2m |
Accounts Payable | 6.4m |
Accrued Liabilities | 2.2m |
Short-Term Debt | 815k |
Other Current Liabilities | 13.8m |
Non-Current Liabilities | 13.3m |
Long-Term Debt | 12.8m |
Other Non-Current Liabilities | 504k |
Earnings Waterfall
Polynovo Ltd
Revenue
|
104.7m
AUD
|
Cost of Revenue
|
-5.5m
AUD
|
Gross Profit
|
99.2m
AUD
|
Operating Expenses
|
-96.6m
AUD
|
Operating Income
|
2.7m
AUD
|
Other Expenses
|
2.6m
AUD
|
Net Income
|
5.3m
AUD
|
Free Cash Flow Analysis
Polynovo Ltd
AUD | |
Free Cash Flow | AUD |
PNV Profitability Score
Profitability Due Diligence
Polynovo Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Polynovo Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
PNV Solvency Score
Solvency Due Diligence
Polynovo Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Polynovo Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PNV Price Targets Summary
Polynovo Ltd
According to Wall Street analysts, the average 1-year price target for PNV is 2.82 AUD with a low forecast of 2.37 AUD and a high forecast of 3.15 AUD.
Dividends
Current shareholder yield for PNV is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
PNV Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Polynovo Ltd. engages in the provision biodegradable medical devices. The company is headquartered in Melbourne, Victoria and currently employs 122 full-time employees. The Company’s principal activity is the development of medical devices for various applications. The Company’s products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM is a man-made synthetic polymer that does not contain any biologic materials. BTM is a skin treatment. NovoSorb is a polymer, which is utilizes for the manufacture of novel medical devices, such as Biocompatible polymers. These biocompatible polymers are designed to support different functions of the body and then biodegrade into by-products that can be absorbed and excreted by the body. The company can be produced in a range of formats with different mechanical and degradation properties. In addition to NovoSorb BTM, they can be used for thermoplastic extrusions, filaments for weaving or knitting and as a solution for spray or dip coatings of other devices.
Contact
IPO
Employees
Officers
The intrinsic value of one PNV stock under the Base Case scenario is 0.81 AUD.
Compared to the current market price of 1.98 AUD, Polynovo Ltd is Overvalued by 59%.